Sleep Apnea and Atrial Fibrillation: How They’re Connected

Research points to a strong link between obstructive sleep apnea and atrial fibrillation. Learn why treating both conditions is crucial.

7:00 AM

Author | Jane Racey Gleeson

After diagnosing a patient with atrial fibrillation, a doctor might recommend testing for obstructive sleep apnea, or OSA.

MORE FROM MICHIGAN: Sign up for our weekly newsletter

The reason: "Obstructive sleep apnea is highly associated with atrial fibrillation," says Krit Jongnarangsin, M.D., an electrophysiologist at the University of Michigan Frankel Cardiovascular Center.

Atrial fibrillation, or Afib, affects an estimated 6 million Americans. It is an arrhythmia characterized by a quivering or irregular heartbeat that can lead to stroke and other heart-related complications.

Although atrial fibrillation can have a range of causes — age, heart disease and hypertension among them — research reveals a strong link between Afib and OSA.

About half of Afib patients have OSA.

People with OSA experience a blockage in the airway, or restricted breathing, for 10 seconds or longer during sleep. The condition can range from mild to severe, based in part on the number of times each hour that a patient stops breathing.

Sleep apnea risk factors

Jongnarangsin recommends that patients diagnosed with Afib be assessed for the following risk factors associated with OSA:

  • Excess weight

  • Narrowed airway

  • Chronic nasal congestion

  • High blood pressure

  • Smoking and alcohol use

  • Age (OSA is more common after age 40)

  • Gender (OSA is more common in men)

  • Family history of OSA

Further examination is needed if risk factors are found.

"We refer them to a sleep specialist, who will screen the patient and, if OSA is diagnosed, recommend continuous positive airway pressure (CPAP) treatment," Jongnarangsin says.

Treating both conditions

CPAP treatment involves wearing a mask during sleep. The mask conducts pressurized air through the nose, or through the nose and mouth, to the throat. The added pressure in the throat then keeps it from collapsing during sleep to enable normal breathing.

SEE ALSO: How Chronic Snoring Can Cause Heart Disease

A patient's Afib is treated in conjunction with CPAP treatment, says Jongnarangsin.

The treatment for Afib is often catheter ablation, a minimally invasive technique in which a catheter is threaded through the blood vessels and into the left atrium of the heart, where radiofrequency or cryo energy is applied to the heart muscle to cauterize the "short circuits" in the heart's electrical system that are generating the Afib.

That method is most effective when combined with CPAP adherence.

"Ablation is more successful in patients who are using CPAP for their OSA," Jongnarangsin says. "If a patient is diagnosed with OSA but not treated for it, the Afib recurrence following ablation is much higher than in patients without obstructive sleep apnea."

That's why it's crucial for Afib patients and their health care providers to discuss the possibility of OSA and, if detected, to treat both conditions.


More Articles About: Heart Health Atrial fibrillation (Afib) Sleep Apnea Cardiovascular: Diseases & Conditions
Health Lab word mark overlaying blue cells
Health Lab

Explore a variety of healthcare news & stories by visiting the Health Lab home page for more articles.

Media Contact Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe
Featured News & Stories smart watch on wrist
Health Lab
Clinical smart watch finds success at identifying atrial fibrillation
A Michigan Medicine research team developed a prescription wristwatch that continuously monitors the wearer’s heart rhythm and uses a unique algorithm to detect atrial fibrillation. The clinical-grade device, called the Verily Study Watch, proved very accurate at identifying atrial fibrillation in participants.
supar molecule teal blue yellow red
Health Lab
Immune protein suPAR links viral infection as possible cause of kidney disease
Through a series of experiments in non-human primates, mice and humans, a multi-institutional team led by researchers from Michigan Medicine and Rush University found that the immune protein soluble urokinase plasminogen activator receptor, or suPAR, is an important link between viral infections and proteinuria; the elevation of protein in the urine is known to cause glomerulopathy, a common form of kidney disease.
heart organ yellow blue
Health Lab
Irregular heartbeat after valve surgery increases risk of stroke, death
Postoperative atrial fibrillation, commonly known as Afib, has traditionally been viewed as benign and limited. But a study led by researchers at the University of Michigan Health Frankel Cardiovascular Center finds that postoperative atrial fibrillation increases the risk of strokes and permanent Afib — and is linked to worse long term survival — after heart valve surgery.
human organ for transplant
Health Lab
Findings shed light on how a pediatric heart surgery complication impacts heart transplant survival
Patients who experience this condition following the Fontan continue to have a high risk of death from the time they’re waitlisted for a new heart through receiving the transplant, according to a 20-center study led by Michigan Medicine. And one specific complication called cyanosis – or experiencing less than normal oxygen blood levels – was associated with worsened survival.
Brain image highlighting areas
Health Lab
Women stroke survivors believe they will receive worse care in the emergency room
National study examined health care perceptions of approximately 3,500 women, including those with and without a history of stroke
surgeons in OR with blue and teal scrubs with screen on and patient under teal sheet
Health Lab
Treating heart valve disease: What are your options?
Michigan Medicine’s head of cardiac surgery, Gorav Ailawadi, M.D, M.B.A., answers questions about different treatment options for heart valve disease.